Findings indicate a serine/glycine-free diet can reduce colorectal cancer growth and enhance immune response, offering ...

Replimune's BLA submission and promising pipeline drugs are set to impact the global melanoma therapeutics market. Read more ...

Dana-Farber Cancer Institute authors: Giuseppe Tarantino, PhD, David Liu, MD, MPH ...

Discover which therapies are expected to grab the PD/L-1 Market Share @ PD/L-1 Treatment Market Size ...

US-based immuno-oncology company Aulos Bioscience has announced the first patients have been dosed as part of a trial ...

Studying patients with PD-1 or PD-L1 deficiency may help inform new approaches to fine-tuning immunotherapies to maximise ...

A research team from the Shanghai Institute of Nutrition and Health (SINH) of the Chinese Academy of Sciences has revealed that aging specifically impairs the generation of CD8+ tissue resident memory ...

A multinational collaboration co-led by the Garvan Institute of Medical Research has uncovered a potential explanation for why some cancer patients receiving a type of immunotherapy called checkpoint ...

Compugen (CGEN) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium - Now At 40% ...

In a study published in Nature Aging on Nov. 26, a research team from the Shanghai Institute of Nutrition and Health (SINH) ...

Compugen (CGEN) announced that the United States Patent and Trademark Office has granted the company a new patent covering method of use for ...